About
Icamunobio develops cell therapies based on induced pluripotent stem cells (iPSC), gene editing, and AI-driven cell differentiation technologies to create universal, effective, and affordable treatments focused on tumor immunotherapy and regenerative medicine.
Explore Icamunobio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.